µç»°¾Ù±¨£º0591-38265150
Óʼþ¾Ù±¨£ºcosunterjb@163.com
Ðżþ¾Ù±¨£º¸£½¨Ê¡¸£ÖݸßÐÂÇøÎÚÁú½ÖдóµÀ7ºÅÁ¢ÒìÔ°¶þÆÚ16ºÅÂ¥£¬ÓÊÕþ±àÂ룺350003£¬ÊÕ¼þÈË£º¼à²ìÈÏÕæÈË
Ѫ¹ÜÌìÉúËØÑùÂѰ×2£¨Angptl2£©ÊÇÒ»ÖÖÂýÐÔÑ×Ö¢½éÖÊ£¬¿ÉÒÔ´Ùʹϸ°ûÍâ»ùÖʵÄÖØ¹¹¡£ÎÒ¹ú±±¾©´óѧµÚÒ»Ò½ÔºÍõ¹óÇ¿½ÌÊÚÍŶӿËÈÕÍê³ÉµÄÒ»ÏîÑо¿Åú×¢£¬ÂýÐÔÒÒÐ͸ÎÑ×£¨CHB£©»¼ÕßµÄѪÇåAngptl2ˮƽÓë¸ÎÏËά»¯·ÖÆÚ×ÔÁ¦Ïà¹Ø£¬ÓÐÍû×÷Ϊ¸ÎÏËά»¯µÄÐÂÐÍÉúÎï±ê¼ÇÎÓëÌ춬°±Ëá°±»ù×ªÒÆÃ¸ºÍѪС°å±ÈÖµÖ¸Êý£¨APRI£©¡¢HuiÄ£×Ó¡¢FIB-4Ö¸Êý¡¢FornÖ¸ÊýÏà±È£¬ÍŽáÓ¦ÓÃAngptl2µÄÖ¸Êý£¨ACI£©¶ÔÕï¶ÏCHB»¼ÕßÏÔÖø¸ÎÏËά»¯µÄÐÔÄܸü¼Ñ¡£
¸ÃÏîÑо¿ÄÉÈë460ÀýALTˮƽÕý³£»òÇá¶ÈÉý¸ßµÄCHB»¼Õߣ¬223Àý×÷Ϊ½¨Ä£ÐÐÁУ¬237Àý»¼Õß×÷ΪÑéÖ¤ÐÐÁС£Ó¦ÓÃELISAÒªÁì¼ì²âѪÇåAngptl2ˮƽ£¬Æ¾Ö¤Ishak±ê×¼£¬ÆÀ¹ÀÏËά»¯ÆÀ·Ö£¬ÏÔÖø¸ÎÏËά»¯µÄ½ç˵ΪIshakÆÀ·Ö ¡Ý 3£¬ÆÀ¹ÀAngptl2×÷Ϊ¸Î×é֯ѧÐÂÐÍÉúÎï±ê¼ÇÎïµÄÕ¹Íû¼ÛÖµ¡£
Ч¹ûÅú×¢£¬½¨Ä£ÐÐÁкÍÑéÖ¤ÐÐÁл¼ÕßµÄѪÇåAngptl2ˮƽ¾ùÓë¸ÎÏËά»¯ÆÀ·ÖÏÔÖøÏà¹Ø¡£ÔÚ½¨Ä£ÐÐÁÐÖУ¬»ùÓÚAngptl2ºÍͨÀý±äÁ¿£¬½¨ÉèACI£¬ÓÃÓÚÕ¹ÍûÏÔÖø¸ÎÏËά»¯µÄÊÜÊÔÕßÊÂÇéÌØÕ÷ÇúÏßÏÂÃæ»ý£¨AUC£©Îª0.835£¬ÏÔÖøÓÅÓÚAPRI £¨AUC = 0.776£¬P = 0.049£©¡¢FIB-4£¨AUC = 0.750£¬P = 0.010£©ºÍHuiÄ£×Ó£¨AUC = 0.756£¬P = 0.028£©£¬²¢ÇÒÓÐÓÅÓÚFornÖ¸ÊýµÄÇ÷ÊÆ£¨AUC = 0.796£¬P = 0.083£©¡£ÔÚÑéÖ¤ÐÐÁÐÖÐ֤ʵ£¬ACIÓÃÓÚÕ¹ÍûCHB»¼ÕßÏÔÖøÐÔ¸ÎÏËά»¯¾ßÓнϺõÄ׼ȷÐԺͿɿ¿ÐÔ¡£
ÔÎÄÁ´½Ó£ºDeng Y, Zhao H, Zhou J, et al. Angiopoietin-like Protein as a Novel Marker for Liver Fibrosis in Chronic Hepatitis B Patients with Normal To Minimally Raised ALT. BMC Infect Dis. 2017 Sep 29;17(1):650.

Ãö¹«Íø°²±¸ 35092602000113ºÅ